Zhou Xin is senior vice president for public affairs at artificial intelligence-driven molecular imaging company Evomics Medical in Shanghai and executive chief editor of AI community platform The Yuan.
Believing that artificial intelligence could make China a greater strategic threat, the administration of U.S. President Joe Biden has set its sights on holding back its rival's AI development.
